Teva Pharmaceutical Industries Ltd (NYSE:TEVA)
| 11.57 Delayed Data As of Aug 13 |  -0.07 / -0.60%Today’s Change | 6.07 Today|||52-Week Range 13.76 | +18.06% Year-to-Date |
Latest TEVA News | Press Releases
| Harmony Biosciences Starts U.S. IPO Effort Jul 31 / Seeking Alpha - Paid Partner Content | Teva announces filing of Ajovy application in Japan Jul 29 / Seeking Alpha - Paid Partner Content |
| Craving Healthcare: A Beginner's Guide And My 7 Picks Jul 31 / Seeking Alpha - Paid Partner Content |
Today’s Trading
| Previous close | 11.64 |
| Today’s open | 11.62 |
| Day’s range | 11.55 - 11.83 |
| Volume | 42 |
| Average volume (3 months) | 10,593,998 |
| Market cap | $13.1B |
Data as of 3:59pm ET, 08/13/2020
Growth & Valuation
| Earnings growth (last year) | +60.78% |
| Earnings growth (this year) | +4.53% |
| Earnings growth (next 5 years) | +3.63% |
| Revenue growth (last year) | -9.92% |
| P/E ratio | 1,157.0 |
| Price/Sales | 0.63 |
| Price/Book | 0.93 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| BGNEBeigene Ltd | +2.15 | +1.01% |
| BBIOBridgeBio Pharma Inc | +0.22 | +0.76% |
| --Immunotech Laborator... | 0.00 | 0.00% |
Data as of 3:59pm ET, 08/13/2020
Financials
| Next reporting date | October 29, 2020 |
| EPS forecast (this quarter) | $0.59 |
| Annual revenue (last year) | $16.9B |
| Annual profit (last year) | -$1.0B |
| Net profit margin | -5.92% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Generic |
No executives to display |
Corporate headquarters Petach Tikva, Hamerkaz |
Forecasts
